ACCESS DAXXIFY Trademark

Trademark Overview


On Monday, November 6, 2023, a trademark application was filed for ACCESS DAXXIFY with the United States Patent and Trademark Office. The USPTO has given the ACCESS DAXXIFY trademark a serial number of 98256507. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 3, 2024. This trademark is owned by Revance Therapeutics, Inc.. The ACCESS DAXXIFY trademark is filed in the Insurance & Financial Services category with the following description:

Financial management of patient reimbursement programs; Financial administration of medication reimbursement programs; Providing patient financial support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance claims processing information in the nature of information about insurance authorization forms and appeals, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims
access daxxify

General Information


Serial Number98256507
Word MarkACCESS DAXXIFY
Filing DateMonday, November 6, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements


Description of MarkThe mark consists of the words "ACCESS" in lower case, stylized letters and "DAXXIFY" in stylized capital letters. The word "ACCESS" is within a parallelogram design which appears to the left of the word "DAXXIFY". There are two arrows that form a partial circle. The upper arrow begins at the first letter "S" in the word "ACCESS" and connects to the letter "A" in the word "DAXXIFY". The lower arrow begins at the letter "A" in the word "DAXXIFY" and connects to the first letter "S" in the word "ACCESS".
Goods and ServicesFinancial management of patient reimbursement programs; Financial administration of medication reimbursement programs; Providing patient financial support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance claims processing information in the nature of information about insurance authorization forms and appeals, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, December 2, 2023
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameRevance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023NEW APPLICATION ENTERED
Tuesday, December 5, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2024ASSIGNED TO EXAMINER
Monday, June 17, 2024NON-FINAL ACTION E-MAILED
Monday, June 17, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED